Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 8102589, 6 pages
https://doi.org/10.1155/2017/8102589
Review Article

Exclusive Enteral Nutrition Induces Remission in Pediatric Crohn’s Disease via Modulation of the Gut Microbiota

1Department of Central Laboratories and Gastroenterology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao 266071, China
2Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao 266071, China
3Department of Emergency Surgery, The Fifth People’s Hospital of Jinan, Jinan 250022, China

Correspondence should be addressed to Quanjiang Dong; ten.haey@bcwyfdq

Received 10 June 2017; Revised 22 August 2017; Accepted 12 September 2017; Published 16 October 2017

Academic Editor: Dimitrios P. Bogdanos

Copyright © 2017 Dawei Gong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. R. Otley, R. K. Russell, and A. S. Day, “Nutritional therapy for the treatment of pediatric Crohn's disease,” Expert Review of Clinical Immunology, vol. 6, no. 4, pp. 667–676, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Borrelli, L. Cordischi, M. Cirulli et al., “Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: a randomized controlled open-label trial,” Clinical Gastroenterology and Hepatology, vol. 4, no. 6, pp. 744–753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Levine, D. Turner, T. P. Gik et al., “Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: Evaluation of the porto IBD group “growth relapse and outcomes with therapy” (GROWTH CD) study,” Inflammatory Bowel Diseases, vol. 20, no. 2, pp. 278–285, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. Z. Grover, R. Muir, and P. Lewindon, “Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease,” Journal of Gastroenterology, vol. 49, no. 4, pp. 638–645, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. F. M. Ruemmele, G. Veres, K. L. Kolho et al., “Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease,” Journal of Crohn's and Colitis, vol. 8, no. 10, pp. 1179–1207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. F. M. Ruemmele, B. Pigneur, and H. Garnier-Lengliné, “Enteral nutrition as treatment option for Crohn's disease: In kids only?” Nestle Nutrition Institute Workshop Series, vol. 79, pp. 115–123, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. N. W. Palm, M. R. de Zoete, T. W. Cullen et al., “Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease,” Cell, vol. 158, no. 5, pp. 1000–1010, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Andoh, H. Kuzuoka, T. Tsujikawa et al., “Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease,” Journal of Gastroenterology, vol. 47, no. 12, pp. 1298–1307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Sha, B. Xu, X. Wang et al., “The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease,” Diagnostic Microbiology and Infectious Disease, vol. 75, no. 3, pp. 245–251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Sokol, V. Leducq, H. Aschard et al., “Fungal microbiota dysbiosis in IBD,” Gut, pp. 1039–1048, 2016. View at Google Scholar
  11. J. Sabino, S. Vieira-Silva, K. Machiels et al., “Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD,” Gut, vol. 65, no. 10, pp. 1681–1689, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Fujimoto, H. Imaeda, K. Takahashi et al., “Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease,” Journal of Gastroenterology and Hepatology, vol. 28, no. 4, pp. 613–619, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Gevers, S. Kugathasan, L. A. Denson et al., “The treatment-naive microbiome in new-onset Crohn's disease,” Cell Host & Microbe, vol. 15, no. 3, pp. 382–392, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D. N. Frank, A. L. S. Amand, R. A. Feldman, E. C. Boedeker, N. Harpaz, and N. R. Pace, “Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 104, no. 34, pp. 13780–13785, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Mukhopadhya, R. Hansen, E. M. El-Omar, and G. L. Hold, “IBD—what role do Proteobacteria play?” Nature Reviews Gastroenterology & Hepatology, vol. 9, no. 4, pp. 219–230, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. S. Day and R. N. Lopez, “Exclusive enteral nutrition in children with crohn's disease,” World Journal of Gastroenterology, vol. 21, no. 22, pp. 6809–6816, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Lionetti, M. L. Callegari, and S. Ferrari, “Enteral nutrition and microflora in pediatric Crohn’s disease,” Journal of Parenteral and Enteral Nutrition, vol. 29, no. 4, supplement, pp. S173–S178, 2005. View at Publisher · View at Google Scholar
  18. H. Shiga, T. Kajiura, J. Shinozaki et al., “Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition,” Digestive and Liver Disease, vol. 44, no. 9, pp. 736–742, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Quince, U. Z. Ijaz, N. Loman et al., “Extensive modulation of the fecal metagenome in children with Crohn's disease during exclusive enteral nutrition,” American Journal of Gastroenterology, vol. 110, no. 12, pp. 1718–1730, 2015. View at Google Scholar · View at Scopus
  20. J. D. Lewis, E. Z. Chen, R. N. Baldassano et al., “Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's dsease,” Cell Host & Microbe, vol. 18, no. 4, pp. 489–500, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Guinet-Charpentier, P. Lepage, A. Morali, M. Chamaillard, and L. Peyrin-Biroulet, “Effects of enteral polymeric diet on gut microbiota in children with Crohn's disease,” Gut, vol. 66, pp. 194-195, 2017. View at Google Scholar · View at Scopus
  22. T. Schwerd, K. Frivolt, T. Clavel et al., “Exclusive enteral nutrition in active pediatric Crohn disease: Effects on intestinal microbiota and immune regulation,” The Journal of Allergy and Clinical Immunology, vol. 138, no. 2, pp. 592–596, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. N. O. Kaakoush, A. S. Day, S. T. Leach, D. A. Lemberg, S. Nielsen, and H. M. Mitchell, “Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn's disease,” Clinical and Translational Gastroenterology, vol. 6, no. 1, article e71, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. J. L. Round and S. K. Mazmanian, “The gut microbiota shapes intestinal immune responses during health and disease,” Nature Reviews Immunology, vol. 9, no. 5, pp. 313–323, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. P. J. Parekh, L. A. Balart, and D. A. Johnson, “The influence of the gut microbiome on obesity, metabolic syndrome and gastrointestinal disease,” Clinical and Translational Gastroenterology, vol. 6, no. 6, article e91, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Sakaguchi, K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi, “Regulatory T cells: how do they suppress immune responses?” International Immunology, vol. 21, no. 10, pp. 1105–1111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. K. Lathrop, S. M. Bloom, S. M. Rao et al., “Peripheral education of the immune system by colonic commensal microbiota,” Nature, vol. 478, no. 7368, pp. 250–254, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. I. I. Ivanov, K. Atarashi, N. Manel et al., “Induction of intestinal Th17 cells by segmented filamentous bacteria,” Cell, vol. 139, no. 3, pp. 485–498, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Atarashi, T. Tanoue, K. Oshima et al., “Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota,” Nature, vol. 500, no. 7461, pp. 232–236, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. L. Round and S. K. Mazmanian, “Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 107, no. 27, pp. 12204–12209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Atarashi, T. Tanoue, T. Shima et al., “Induction of colonic regulatory T cells by indigenous Clostridium species,” Science, vol. 331, no. 6015, pp. 337–341, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. N. O. Kaakoush, A. S. Day, K. D. Huinao et al., “Microbial dysbiosis in pediatric patients with Crohn's disease,” Journal of Clinical Microbiology, vol. 50, no. 10, pp. 3258–3266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Imhann, A. V. Vila, M. J. Bonder et al., “Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease,” Gut, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. K. J. Maloy and F. Powrie, “Intestinal homeostasis and its breakdown in inflammatory bowel disease,” Nature, vol. 474, no. 7351, pp. 298–306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Takahashi, A. Nishida, T. Fujimoto et al., “Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn's disease,” Digestion, vol. 93, no. 1, pp. 59–65, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Sokol, B. Pigneur, L. Watterlot et al., “Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 105, no. 43, pp. 16731–16736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. C. R. Hedin, N. E. McCarthy, P. Louis et al., “Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn's disease and their unaffected siblings,” Gut, vol. 63, no. 10, pp. 1578–1586, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Hedin, C. J. van der Gast, G. B. Rogers et al., “Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities,” Gut, vol. 65, no. 6, pp. 944–953, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Levy, E. Blacher, and E. Elinav, “Microbiome, metabolites and host immunity,” Current Opinion in Microbiology, vol. 35, pp. 8–15, 2017. View at Google Scholar
  40. E. Gaudier, A. Jarry, H. M. Blottière et al., “Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 287, no. 6, pp. G1168–G1174, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Macia, J. Tan, A. T. Vieira et al., “Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome,” Nature Communications, vol. 6, article 7734, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. M. A. R. Vinolo, H. G. Rodrigues, E. Hatanaka, F. T. Sato, S. C. Sampaio, and R. Curi, “Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils,” The Journal of Nutritional Biochemistry, vol. 22, no. 9, pp. 849–855, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Usami, K. Kishimoto, A. Ohata et al., “Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells,” Nutrition Research, vol. 28, no. 5, pp. 321–328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. P. M. Smith, M. R. Howitt, N. Panikov et al., “The microbial metabolites, short-chain fatty acids, regulate colonic T reg cell homeostasis,” Science, vol. 341, no. 6145, pp. 569–573, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Singh, A. Gurav, S. Sivaprakasam et al., “Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis,” Immunity, vol. 40, no. 1, pp. 128–139, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. W. Scheppach, H. Sommer, T. Kirchner et al., “Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis,” Gastroenterology, vol. 103, no. 1, pp. 51–56, 1992. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Schaubeck, T. Clavel, J. Calasan et al., “Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence,” Gut, vol. 65, no. 2, pp. 225–237, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. S. T. Leach, H. M. Mitchell, W. R. Eng, L. Zhang, and A. S. Day, “Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn's disease,” Alimentary Pharmacology & Therapeutics, vol. 28, no. 6, pp. 724–733, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Duboc, S. Rajca, D. Rainteau et al., “Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases,” Gut, vol. 62, no. 4, pp. 531–539, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. X. C. Morgan, T. L. Tickle, H. Sokol et al., “Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment,” Genome Biology, vol. 13, no. 9, article R79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Gerasimidis, M. Bertz, L. Hanske et al., “Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition,” Inflammatory Bowel Diseases, vol. 20, no. 5, pp. 861–871, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Berntson, P. Agback, and J. Dicksved, “Changes in fecal microbiota and metabolomics in a child with juvenile idiopathic arthritis (JIA) responding to two treatment periods with exclusive enteral nutrition (EEN),” Clinical Rheumatology, vol. 35, no. 6, pp. 1501–1506, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Berntson, I. Hedlund-Treutiger, and K. Alving, “Anti-inflammatory effect of exclusive enteral nutrition in patients with juvenile idiopathic arthritis,” Clinical and Experimental Rheumatology, vol. 34, no. 5, pp. 941–945, 2016. View at Google Scholar · View at Scopus
  54. C. Walton, M. P. B. Montoya, D. P. Fowler et al., “Enteral feeding reduces metabolic activity of the intestinal microbiome in Crohn's disease: An observational study,” European Journal of Clinical Nutrition, vol. 70, no. 9, pp. 1052–1056, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. E. Holmes, J. V. Li, T. Athanasiou, H. Ashrafian, and J. K. Nicholson, “Understanding the role of gut microbiome-host metabolic signal disruption in health and disease,” Trends in Microbiology, vol. 19, no. 7, pp. 349–359, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, “An obesity-associated gut microbiome with increased capacity for energy harvest,” Nature, vol. 444, no. 7122, pp. 1027–1031, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. W. Mottawea, C.-K. Chiang, M. Mühlbauer et al., “Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease,” Nature Communications, vol. 7, Article ID 13419, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Everard, L. Geurts, R. Caesar et al., “Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status,” Nature Communications, vol. 5, article 5648, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. E. Denou, K. Lolmède, L. Garidou et al., “Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance,” EMBO Molecular Medicine, vol. 7, no. 3, pp. 259–274, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Vijay-Kumar, J. D. Aitken, F. A. Carvalho et al., “Metabolie syndrome and altered gut microbiota in mice lacking toll-like receptor 5,” Science, vol. 328, no. 5975, pp. 228–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. E. Gianchecchi and A. Fierabracci, “On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota,” Immunologic Research, vol. 65, no. 1, pp. 242–256, 2017. View at Publisher · View at Google Scholar · View at Scopus
  62. J. C. Needell and D. Zipris, “The role of the intestinal microbiome in type 1 diabetes pathogenesis,” Current Diabetes Reports, vol. 16, no. 10, article 89, 2016. View at Publisher · View at Google Scholar · View at Scopus
  63. A. E. Livanos, T. U. Greiner, P. Vangay et al., “Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice,” Nature Microbiology, vol. 1, Article ID 16140, 2016. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Lamas, M. L. Richard, V. Leducq et al., “CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands,” Nature Medicine, vol. 22, no. 6, pp. 598–605, 2016. View at Publisher · View at Google Scholar · View at Scopus
  65. K. L. Arnolds and C. A. Lozupone, “Striking a balance with help from our little friends—how the gut microbiota contributes to immune homeostasis,” Yale Journal of Biology and Medicine, vol. 89, no. 3, pp. 389–395, 2016. View at Google Scholar · View at Scopus
  66. L. Cervantes-Barragan, J. N. Chai, M. D. Tianero et al., “Lactobacillus reuteri induces gut intraepithelial CD4+CD8alphaalpha+ T cells,” Science, vol. 357, no. 6353, pp. 806–810, 2017. View at Google Scholar
  67. C.-L. N. Small, S. A. Reid-Yu, J. B. McPhee, and B. K. Coombes, “Persistent infection with Crohn's disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis,” Nature Communications, vol. 4, p. 1957, 2013. View at Google Scholar · View at Scopus
  68. K. A. Dunn, J. Moore-Connors, B. Macintyre et al., “Early changes in microbial community structure are associated with sustained remission after nutritional treatment of pediatric Crohn's disease,” Inflammatory Bowel Diseases, vol. 22, no. 12, pp. 2853–2862, 2016. View at Publisher · View at Google Scholar · View at Scopus
  69. V. D'Argenio, V. Precone, G. Casaburi et al., “An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy,” American Journal of Gastroenterology, vol. 108, no. 5, pp. 851-852, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. L. Chen, W. Wang, R. Zhou et al., “Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease,” Medicine, vol. 93, no. 8, article e51, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. N. Dey, D. A. W. Soergel, S. Repo, and S. E. Brenner, “Association of gut microbiota with post-operative clinical course in Crohn's disease,” BMC Gastroenterology, vol. 13, no. 1, article 131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Bel, Y. Elkis, H. Elifantz et al., “Reprogrammed and transmissible intestinal microbiota confer diminished susceptibility to induced colitis in TMF−/− mice,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 111, no. 13, pp. 4964–4969, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. F. Isbell, D. Craven, J. Connolly et al., “Biodiversity increases the resistance of ecosystem productivity to climate extremes,” Nature, vol. 526, no. 7574, pp. 574–577, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. K. Z. Coyte, J. Schluter, and K. R. Foster, “The ecology of the microbiome: Networks, competition, and stability,” Science, vol. 350, no. 6261, pp. 663–666, 2015. View at Publisher · View at Google Scholar · View at Scopus